Novavax Inc (NVAX)

Total Costs & Expenses

$111.60M

Quarterly · Period ending: · USD

NVAX logo

NVAX Total Costs & Expenses

Latest reported$111.60M
NVAX Quarterly Total Costs & Expenses ($1.20M → $111.60M)
High-resolution chart · PNG

NVAX total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novavax Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
111,604,000
154,944,000
126,119,000
248,463,000
133,570,000
151,142,000
219,391,000
218,530,000
254,486,000
232,586,000
474,910,000
147,696,000
368,969,000
306,340,000
531,705,000
861,766,000
668,885,000
395,378,000
98,462,000
485,988,000
643,846,000
655,861,000
462,512,000
350,966,000
52,565,000
26,274,000
37,521,000
26,510,000
40,023,000
44,205,000
52,639,000
49,635,000
52,766,000
53,166,000
58,197,000
49,980,000
48,203,000
46,506,000
59,444,000
66,539,000
79,003,000
79,480,000
84,755,000
39,724,000
34,817,000
34,190,000
38,388,000
28,003,000
26,110,000
21,847,000
23,001,000
20,081,000
16,429,000
13,838,000
14,061,000
12,614,000
12,958,000
12,109,000
10,104,000
8,976,000
8,922,000
8,264,000
7,083,000
10,714,000
9,475,000
11,564,000
14,228,000
8,463,000
7,859,000
7,158,000
9,280,000
9,920,000
8,546,000
7,678,000
2,667,000
10,572,000
8,883,000
9,660,000
8,188,000
6,887,000
7,877,000
6,338,000
-4,464,000
4,104,000
7,540,000
9,379,000
11,954,000
2,973,000
10,345,000
8,116,000
7,108,000
7,229,000
6,907,000
6,595,000
6,591,000
8,806,000
9,979,000
11,188,000
9,165,000
7,410,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.